Adaptogenics Health Corp. Announces Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - August 14, 2026) - Adaptogenics Health Corp. (CSE: ADPT) ("Adaptogenics", the "Company") is pleased to announce it is launching a non-brokered private placement of up to 4,000,000 common shares (the "Shares"), at a price of $0.08 per Share for gross proceeds of up to $320,000 (the "Offering"). The Company will use the net proceeds from the Offering for general working capital. The Comp
Household / Consumer / Cosmetics, Psychedelics
2026-08-14 6:56 PM EDT | Adaptogenics Health Corp.
Hanf.com Transaction Advances as Neural Therapeutics Receives CSE Conditional Approval
Toronto, Ontario--(Newsfile Corp. - August 14, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company") is pleased to announce that it has received conditional approval from the Canadian Securities Exchange (the "CSE") for the listing of the Company's shares following completion of its previously announced fundamental change transaction involving CWE European Holdings Inc. ("CWE"), which operates the Hanf.com business in Germany (
Biotechnology, Pharmaceuticals, Health, Psychedelics
2026-08-14 5:01 PM EDT | Neural Therapeutics Inc.
Rhelion Life Sciences Signs Agreement with University Health Network for Randomized Clinical Trial of Psilocybin in Parkinson's Disease Depression
Toronto, Ontario--(Newsfile Corp. - August 14, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX) (OTCQB: TRUFF) ("Rhelion" or the "Company") an Ontario-based organization advancing innovation and research within the legal psy
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-08-14 8:14 AM EDT | Rhelion Life Sciences Corp.
Experience Onward Acquires 36 Acre Colorado Property to Launch Onward Ranch, a Legal Psilocybin and Wellness Retreat Destination
Denver, Colorado--(Newsfile Corp. - August 11, 2026) - Experience Onward, founded by former NHL player and two time Stanley Cup champion Daniel Carcillo, today announced the acquisition of a private, 36 acre mountain property in Colorado that is now progressing through the state licensing process to become a legal psilocybin retreat destination. Named Onward Ranch, the property is being developed as a first of its kind residential retreat environment designed to bring legal, regu
2026-08-11 9:00 AM EDT | Experience Onward
Adaptogenics Health Corp. Announces Change of Directors
Vancouver, British Columbia--(Newsfile Corp. - August 6, 2026) - Adaptogenics Health Corp. (CSE: ADPT) ("Adaptogenics", the "Company") is pleased to announce the appointment of Mr. Gurinder Sandhu as a director of the Company effective immediately. Mr. Sandhu is the founder of a proprietary health technology company that combines continuous health monitoring with clinical decision support. His experience includes corporate strategy, commercialization, and tran
Household / Consumer / Cosmetics, Psychedelics
2026-08-06 8:00 PM EDT | Adaptogenics Health Corp.
Psyched Wellness Announces Secured Term Loan
Toronto, Ontario--(Newsfile Corp. - August 5, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production and distribution of Amanita Muscaria-derived health and wellness products, announces that it has entered into secured term notes (the "Notes") with Gotham Green Fund III, L.P. and Gotham Green Fund III (Q), L.P. (together the "Lenders") for an aggregate principal am
Cannabis, Health, Psychedelics, Cannabis Manufacturer
2026-08-05 9:00 AM EDT | Psyched Wellness Ltd.
Rhelion Life Sciences Corp. Commences Trading Under New Name and Ticker Symbol RHEL on the CSE
Toronto, Ontario--(Newsfile Corp. - August 4, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (OTCQB: TRUFF) (FSE: 4YX) ("Rhelion" or the "Company") is pleased to announce that it has completed its corporate name change from Red Light Holland Corp. to Rhelion Life Sciences Corp. and changed its ticker symbol on the Canadian Securities Exchange (the "CSE") from "TRIP" to "RHEL" (collectively, the "Name and Ticker Change"). The Company's common shares (the "
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-08-04 9:00 PM EDT | Rhelion Life Sciences Corp.
Psyched Wellness Launches Strategic Review to Unlock Shareholder Value
Toronto, Ontario--(Newsfile Corp. - July 29, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) ("Psyched Wellness" or the "Company"), a life sciences company focused on the production and distribution of health and wellness products derived from the Amanita Muscaria mushroom, announces that its Board of Directors has commenced a strategic review process designed to evaluate opportunities to enhance and accelerate value creation for shareholders ("Strategic Review").
Cannabis, Health, Psychedelics, Cannabis Manufacturer
2026-07-29 5:42 PM EDT | Psyched Wellness Ltd.
Red Light Holland Reports Fiscal 2026 Audited Year-End Results and Provides Update on Rhelion Life Sciences
Toronto, Ontario--(Newsfile Corp. - July 29, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based organization advancing innovation and research within the legal psychedelic sector, is pleased to report its audited annual consolidated financial statements and management's discussion and analysis ("MD&A") for the fiscal years ended March 31, 2026 and 2025. All figures are reported in Canadian dol
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-07-29 7:53 AM EDT | Rhelion Life Sciences Corp.
Optimind Pharma Announces Adoption of Semi-Annual Reporting
Toronto, Ontario--(Newsfile Corp. - July 24, 2026) - Optimind Pharma Corp. (CSE: OMND) ("Optimind" or the "Company") announces that it has elected to voluntarily adopt semi-annual financial reporting and rely on the exemptions in Coordinated Blanket Order 51-933 - Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers ("CBO 51-933"). Introduced by the Canadian Securities Administrators (CSA), the pilot program under CBO 51-933 allows eligible venture issuers to voluntari
Biotechnology, Cannabis, Health, Psychedelics
2026-07-24 9:04 AM EDT | Optimind Pharma Corp.
Red Light Holland Announces Corporate Rebrand to Rhelion Life Sciences Corp
Toronto, Ontario--(Newsfile Corp. - July 17, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light" or the "Company") is pleased to announce that it will be changing its corporate name to Rhelion Life Sciences Corp ("Rhelion"), marking
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-07-17 7:50 AM EDT | Rhelion Life Sciences Corp.
Red Light Holland Announces New Filament Health PEX010 European Research Shipment
Toronto, Ontario--(Newsfile Corp. - July 16, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland", "Red Light", or the "Company") is an Ontario based organization advancing innovation and research within the legal psychedelic sector. Following its acquisition of Filament Health Corp. ("Filament"), the Company has expanded its pharmaceutical grade manufacturing, regulatory, and clinical research capabilities, supporting the advancement of naturally derived
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-07-16 8:03 AM EDT | Rhelion Life Sciences Corp.
Adaptogenics Health Corp. Announces Effective Date of Share Consolidation
Vancouver, British Columbia--(Newsfile Corp. - July 14, 2026) - Adaptogenics Health Corp. (CSE: ADPT) ("Adaptogenics", the "Company") is pleased to announce that the Canadian Securities Exchange (the "CSE") has approved the consolidation (the "Consolidation") of the Company's issued and outstanding common shares (the "Common Shares") on the basis of one (1) post-Consolidation Common Share for every four (4) pre-Consolidation Common Shares. The C
Household / Consumer / Cosmetics, Psychedelics
2026-07-14 5:02 PM EDT | Adaptogenics Health Corp.
Adaptogenics Health Corp. Announces Share Consolidation
Vancouver, British Columbia--(Newsfile Corp. - July 8, 2026) - Adaptogenics Health Corp. (CSE: ADPT) ("Adaptogenics", the "Company") announces that it intends to consolidate the common shares of the Company on a four-to-one basis (the "Consolidation"). The Company has 16,397,701 Common Shars outstanding, and if completed, the proposed Consolidation would reduce the issued and outstanding Common Shares to approximately 4,099,425 Common Shares. Subject to re
Household / Consumer / Cosmetics, Psychedelics
2026-07-08 7:11 PM EDT | Adaptogenics Health Corp.
Red Light Holland Announces Filament Health's Largest-Ever Manufacturing Run of PEX010, the Standardized and Patented Natural Psilocybin Drug Candidate Trusted Across 80+ Studies Globally, Now Offering the Widest Standardized Dosing Range, from 0.5 mg to 25 mg
Toronto, Ontario--(Newsfile Corp. - July 8, 2026) -
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-07-08 8:00 AM EDT | Rhelion Life Sciences Corp.
Red Light Holland's Wholly Owned Subsidiary, Filament Health, Signs Agreement to Supply PEX010 Botanical Psilocybin Drug Candidate for Military Veterans PTSD Study at ARQ National Psychotrauma Centre
Toronto, Ontario--(Newsfile Corp. - July 7, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland", "Red Light", or the "Company") is an Ontario based organization advancing innovation and research within the legal psychedelic sector. Following its acquisition of Filament Health Corp. ("Filament"), the Company has expanded its pharmaceutical grade manufacturing, regulatory, and clinical research capabilities, supporting the advancement of naturally derived
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-07-07 8:12 AM EDT | Rhelion Life Sciences Corp.
Neural Therapeutics Inc. Announces Transition to Semi-Annual Financial Reporting
Toronto, Ontario--(Newsfile Corp. - June 19, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company") announces that it has elected to voluntarily adopt semi-annual financial reporting and rely on the exemptions provided under Coordinated Blanket Order 51-933 - Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers ("CBO 51-933"). Introduced by the Canadian Securities Administrators ("CSA"), the pilot program under
Biotechnology, Pharmaceuticals, Health, Psychedelics
2026-06-19 12:16 PM EDT | Neural Therapeutics Inc.
Red Light Holland Reports Positive Preclinical Study Results for Coca in Weight Gain Prevention Post GLP-1 from Magdalena Biosciences, the Joint Venture Held Through Its Wholly Owned Subsidiary, Filament Health
Toronto, Ontario--(Newsfile Corp. - June 18, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland", "Red Light", or the "Company") is an Ontario based organization advancing innovation and research within the legal psychedelic sector. Following its acquisition of Filament Health Corp. ("Filament"), the Company has expanded it
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-06-18 9:01 AM EDT | Rhelion Life Sciences Corp.
Neural Therapeutics Announces AGSM Results, CFO Appointment and Welcomes Positive Developments in the German Cannabis Market
Toronto, Ontario--(Newsfile Corp. - June 12, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company") is pleased to announce the results of its annual general and special meeting of shareholders held on May 25, 2026 (the "Meeting"), including shareholder approval of the acquisition by Neural of the remaining 69.25% equity interest in CWE European Holdings Inc. ("CWE") not already owned by the Company, through a series of ancillary transa
Biotechnology, Pharmaceuticals, Health, Psychedelics
2026-06-12 7:30 AM EDT | Neural Therapeutics Inc.
Psyched Wellness Provides Corporate Update
Toronto, Ontario--(Newsfile Corp. - June 10, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production and distribution of health and wellness products derived from the Amanita Muscaria mushroom, announces that Jeff Stevens has stepped down from his position as Chief Executive Officer and resigned as a director of the Company, each effective May 31, 2026. Mr. Stevens has also resign
Cannabis, Health, Psychedelics, Cannabis Manufacturer
2026-06-10 5:15 PM EDT | Psyched Wellness Ltd.